BiotechTube
Home/Spruce Biosciences/Javier Szwarcberg
JS

Javier Szwarcberg

Chief Executive Officer

Spruce Biosciences

Therapeutic Areas

Neurological DisordersEndocrine DisordersRare DiseasesLysosomal Storage Disorders

Spruce Biosciences Pipeline

DrugIndicationPhase
Tralesinidase Alfa Enzyme Replacement Therapy (TA-ERT)Mucopolysaccharidosis Type IIIB (MPS IIIB / Sanfilippo Syndrome Type B)Phase 3

Leadership Team at Spruce Biosciences

SG
Samir Gharib
President and Chief Financial Officer
KW
Kirk Ways
Chief Medical Officer
DR
Dasharatha Reddy
Vice President, Pharmaceutical Development and Manufacturing
SS
Saba Sile
Vice President, Clinical Development
MG
Michael Grey
Executive Chairman
PB
Percival Barretto-Ko
Independent Director
CV
Camilla V. Simpson
Independent Director
DS
Dan Spiegelman
Independent Director
KW
Keli Walbert
Independent Director
View full Spruce Biosciences profile